Health Sciences News

UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.

{hide_init_page_description}

The Latest

Precision Therapy Could Stop Breast Cancer at the Source

UC San Diego researchers have developed a new targeted therapy for triple-negative breast cancer, the most difficult-to-treat subtype of the disease.

When Life Imitates Art: Google Searches for Anxiety Drug Spike During Run of The White Lotus TV Show

A UC San Diego study suggests that the depiction of lorazepam use on Season 3 of The White Lotus TV series sparked 1.6 million extra Google searches for information about the benzodiazepine drug, including how to acquire it online.

Endowed Chair in Circadian Biology and Medicine Established at UC San Diego

The University of California San Diego has announced that Amir Zarrinpar, M.D., Ph.D., has been appointed as the inaugural holder of the Stuart and Barbara L. Brody Endowed Chair in Circadian Biology and Medicine.

John C. Martin Endowed Chair in Liver Disease Established at UC San Diego

UC San Diego has appointed Rohit Loomba, M.D., as inaugural holder of the John C. Martin Endowed Chair in Liver Disease, which was created to support innovative research and treatment in liver disease.

Annual Stein Symposium Emphasizes Physical, Mental and Cognitive Resilience in Older Adults

Clara Bard, 619-363-5115, scbard@ucsd.edu

GLP-1 Drugs Linked to Dramatically Lower Death Rates in Colon Cancer Patients

In an analysis of more than 6,800 colon cancer patients across all University of California Health sites, researchers found that those taking glucagon-like peptide-1 (GLP-1) medications were less than half as likely to die within five years compared to those who weren’t on the drugs (15.5% vs. 37.1%